BGC201531
BGC201531 is a EP4 antagonist for the treatment of acute migraine.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
496.58
Molecular Formula
C26H28N2O6S
Notes
Research use only, not for human use.
Receptor
EP4
CAS Number
1186532-61-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1059638-01 100 mg
(3S,4R) -4- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -1- (tert-butoxycarbonyl) pyrrolidine-3-carboxylic acid
Ask
View Details 
OR1059638-02 250 mg
(3S,4R) -4- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -1- (tert-butoxycarbonyl) pyrrolidine-3-carboxylic acid
Ask
View Details 
OR1059638-03 1 g
(3S,4R) -4- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -1- (tert-butoxycarbonyl) pyrrolidine-3-carboxylic acid
Ask
View Details 41637141 1x10<sup>6</sup> cells/1.0ml
RPL37P6 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details MBS644967-01 0.05 mg
ACTN3, NT (Alpha-actinin-3, Alpha-actinin Skeletal Muscle Isoform 3, F-actin Cross-linking Protein)
Ask
View Details MBS644967-02 5x 0.05 mg
ACTN3, NT (Alpha-actinin-3, Alpha-actinin Skeletal Muscle Isoform 3, F-actin Cross-linking Protein)
Ask
View Details